388 related articles for article (PubMed ID: 22240256)
41. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA Profile in CD8+ T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression.
Egaña-Gorroño L; Guardo AC; Bargalló ME; Planet E; Vilaplana E; Escribà T; Pérez I; Gatell JM; García F; Arnedo M; Plana M M;
PLoS One; 2016; 11(5):e0155245. PubMed ID: 27171002
[TBL] [Abstract][Full Text] [Related]
43. Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire.
Koblavi-Dème S; Kestens L; Hanson D; Otten RA; Borget MY; Bilé C; Wiktor SZ; Roels TH; Chorba T; Nkengasong JN
AIDS; 2004 Feb; 18(3):413-9. PubMed ID: 15090792
[TBL] [Abstract][Full Text] [Related]
44. Identification of miRNA-mRNA crosstalk in CD4
Liao Q; Wang J; Pei Z; Xu J; Zhang X
J Transl Med; 2017 Feb; 15(1):41. PubMed ID: 28222782
[TBL] [Abstract][Full Text] [Related]
45. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
Hunt PW; Deeks SG; Rodriguez B; Valdez H; Shade SB; Abrams DI; Kitahata MM; Krone M; Neilands TB; Brand RJ; Lederman MM; Martin JN
AIDS; 2003 Sep; 17(13):1907-15. PubMed ID: 12960823
[TBL] [Abstract][Full Text] [Related]
46. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
[TBL] [Abstract][Full Text] [Related]
47. Rate and predictors of progression in elite and viremic HIV-1 controllers.
Leon A; Perez I; Ruiz-Mateos E; Benito JM; Leal M; Lopez-Galindez C; Rallon N; Alcami J; Lopez-Aldeguer J; Viciana P; Rodriguez C; Grau E; Iribarren J; Gatell JM; Garcia F;
AIDS; 2016 May; 30(8):1209-20. PubMed ID: 26854807
[TBL] [Abstract][Full Text] [Related]
48. Vesicular MicroRNA as Potential Biomarkers of Viral Rebound.
Bazié WW; Boucher J; Traoré IT; Kania D; Somé DY; Alary M; Gilbert C
Cells; 2022 Mar; 11(5):. PubMed ID: 35269481
[TBL] [Abstract][Full Text] [Related]
49. Mortality during the first 24 months after delivery in relation to CD4 T-lymphocyte levels and viral load in a cohort of breast-feeding HIV-1-infected women in Dar es Salaam, Tanzania.
Kilewo C; Karlsson K; Swai A; Massawe A; Lyamuya E; Mhalu F; Biberfeld G
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):598-602. PubMed ID: 15793372
[TBL] [Abstract][Full Text] [Related]
50. Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
Vella S; Galluzzo MC; Giannini G; Pirillo MF; Andreotti M; Tomino C; Fragola V; Bucciardini R; Ricciardulli D; Binelli A; Weimer LE; Floridia M
Antiviral Res; 2000 Sep; 47(3):189-98. PubMed ID: 10974371
[TBL] [Abstract][Full Text] [Related]
51. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
52. Unique Circulating MicroRNA Profiles in HIV Infection.
Narla V; Bhakta N; Freedman JE; Tanriverdi K; Maka K; Deeks SG; Ganz P; Hsue P
J Acquir Immune Defic Syndr; 2018 Dec; 79(5):644-650. PubMed ID: 30204717
[TBL] [Abstract][Full Text] [Related]
53. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.
Bailey JR; Lassen KG; Yang HC; Quinn TC; Ray SC; Blankson JN; Siliciano RF
J Virol; 2006 May; 80(10):4758-70. PubMed ID: 16641269
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection.
Mehandru S; Poles MA; Tenner-Racz K; Manuelli V; Jean-Pierre P; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
J Virol; 2007 Jan; 81(2):599-612. PubMed ID: 17065209
[TBL] [Abstract][Full Text] [Related]
55. Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors.
Spivak AM; Salgado M; Rabi SA; O'Connell KA; Blankson JN
J Virol; 2011 Oct; 85(19):10399-403. PubMed ID: 21795348
[TBL] [Abstract][Full Text] [Related]
56. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals.
Rotger M; Dang KK; Fellay J; Heinzen EL; Feng S; Descombes P; Shianna KV; Ge D; Günthard HF; Goldstein DB; Telenti A; ;
PLoS Pathog; 2010 Feb; 6(2):e1000781. PubMed ID: 20195503
[TBL] [Abstract][Full Text] [Related]
57. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.
Rachinger A; Navis M; van Assen S; Groeneveld PH; Schuitemaker H
Clin Infect Dis; 2008 Dec; 47(11):e86-9. PubMed ID: 18947331
[TBL] [Abstract][Full Text] [Related]
58. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
García F; Vidal C; Gatell JM; Miró JM; Soriano A; Pumarola T
AIDS; 1997 Jan; 11(1):53-7. PubMed ID: 9110075
[TBL] [Abstract][Full Text] [Related]
59. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
60. HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.
Côrtes FH; Passaes CP; Bello G; Teixeira SL; Vorsatz C; Babic D; Sharkey M; Grinsztejn B; Veloso V; Stevenson M; Morgado MG
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):377-385. PubMed ID: 25564106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
